NCT05512572 is a NA clinical trial of IPL in Chalazion, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who is sponsoring NCT05512572?

NCT05512572 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

What drugs are being tested in NCT05512572?

Interventions in NCT05512572: IPL, Conservative treatment or excision with curettage.

Is NCT05512572 still recruiting?

NCT05512572 is currently status unknown. Last updated 21 September 2022.

Last reviewed 2022-09-21 · How we verify

NCT05512572

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Therapeutic Efficacy of Intense Pulsed Light in the Treatment of Chalazion

Status unknown NA Last updated 21 September 2022

What this trial tests

NA trial testing IPL in Chalazion in 80 participants. Status unknown.

Timeline

23 August 2021

Primary endpoint
30 October 2021

23 August 2023

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	23 August 2021
Primary completion	30 October 2021
Estimated completion	23 August 2023
Sites	1 location across China

Drugs / interventions tested

IPL
Conservative treatment or excision with curettage

Conditions studied

Chalazion — all drugs for Chalazion →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

18 and older, any sex, with Chalazion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study method: This test screened the subjects first, and proposed to include 50 subjects with primary or recurrent eyelid plate gland cysts without obvious surgical indications. All subjects underwent three strong pulsed light therapy combined with eyelid plate gland massage, treatment of local anesthesia eye drops, and metal pads were placed in conjunctival sac protection. Eye protection, using the M22 strong pulsed light small optical treatment head of the medical company, energy selection 14-16J/cm2, laser position is selected on the upper and lower eyelids, 3mm away from the root of the eyelashes. Each interval is 3 weeks. Eye-related examinations were performed before treatment and 3 times after treatment. The evaluation content included: ocular surface, slit lamp observation, anterior segment photography, intraocular pressure, vision, corneal fluorescein staining, tear film rupture time, eyelid plate gland evaluation, eyelid plate gland cyst relief, eyelid plate gland cyst recurrence rate.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Novel treatment of chalazion using light-guided-tip intense pulsed light.
Zhu Y, Zhao H, Huang X, Lin L, et al · · 2023 · cited 8× · PMID 37524772 · DOI 10.1038/s41598-023-39332-x

Verify or expand the search:

Other trials of IPL

Trials testing the same drug.

NCT07055022 — Low-level Light Therapy Versus Intense Pulsed Light to Prevent Iatrogenic Dry Eye Disease After Cataract Surgery · NA · not yet recruiting
NCT07169461 — Effectiveness of Low Level Light Therapy and Intense Pulse Light on Mite Count as Adjuntive Therapies in Demodex Blephar · NA · enrolling by invitation
NCT05923528 — Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye · NA · unknown
NCT06158984 — Managing Dry Eye in Patients Using Glaucoma Drops · NA · completed
NCT05739799 — To Comapre The Effectiveness of Two Lasers in The Treamment of Unwanted Hair · NA · completed

Other recruiting trials for Chalazion

Currently open trials in the same condition.

NCT07450495 — Effect of Different Concentrations of Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Surgery · NA · recruiting

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05512572 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 21 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05512572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing